Guru Ownership Trend
Guru Analysis for Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.32 B.
Top institutional holders include Cliff Asness and Mason Hawkins.
Institutional sentiment is currently Bullish. This is evidenced by a $43.93 M net inflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 125.9%. Conversely, Cliff Asness reduced exposure by 8.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Regeneron Pharmaceuticals, Inc. (REGN)
Major holders include Cliff Asness ($702.16 M), Mason Hawkins ($94.98 M), Renaissance Technologies (RenTech) ($92.42 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 1.68 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $43.93 M, with 8 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited REGN. The total reported sell value was $71.04 M.
Yes, 1 managers opened new positions in REGN, and 7 increased their existing holdings. The total reported buy value was $114.97 M.
